title: A response to a recent editorial by concerned physicians on 3,4-diaminopyridine.
authors.affiliation: Catalyst Pharmaceuticals, Inc, Coral Gables, Florida, USA.
authors.forename: Patrick J
authors.initials: PJ
authors.lastname: McEnany
mesh_terms: D015761:4-Aminopyridine / Q000031:analogs & derivatives; D000077770:Amifampridine; D006801:Humans; D009965:Orphan Drug Production
chemical_list: D015761:4-Aminopyridine; D000077770:Amifampridine